Shan et al. fabricated γ-Fe2O3 nanoparticles coated with dimercaptosuccinic acid and modified with 2-deoxy-D-glucose to target GLUT1 for precise diagnosis of the tumor by MRI [91]. The gene discussed is SLC2A1; the disease is neoplasm.